Synta Seals Deal in Inflammatory Diseases with Roche
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 103 (Table of Contents)
Published: 30 Dec-2008
DOI: 10.3833/pdr.v2008.i103.97 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Synta Pharmaceuticals has entered into a partnership with Roche to discover and develop small molecules that target CRACM channels implicated in various inflammatory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS